batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. MacroGenics goes for cash over royalties 10 June 2025 FDA checks checkpoint inhibitors 10 June 2025 Volrustomig's pivotal dish has a casdatifan side helping 6 June 2025 FDA red and green lights: May 2025 4 June 2025 ASCO 2025 – an early split between PD-L1 conjugates 2 June 2025 Sanofi spends $9bn on a new growth Blueprint 2 June 2025 ASCO 2025 – BioNTech has a prostate decision to make 1 June 2025 ASCO 2025 – Bicara's ficerafusp claim turns to PD-L1 status 1 June 2025 Load More